Home › Companies › COHERUS BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and COHERUS BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2025: 6 items on COHERUS BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 3 elected · 3 approved.
Significant dissent: 1 director (28.7% against); 1 say-on-pay vote (54.3% support).
Notable dissent: 2 directors (15.9%, 15.8% against); 1 equity or compensation plan (21.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore COHERUS BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are COHERUS BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jill O'Donnell-Tormey, Ph.D. | 32,769,503 | -- | -- | 6,158,468 | 36,656,283 | 84% | Elected | — |
| Elect Director: Michael Ryan | 32,735,184 | -- | -- | 6,192,787 | 36,656,283 | 84% | Elected | — |
| Elect Director: Ali J. Satvat | 27,759,763 | -- | -- | 11,168,208 | 36,656,283 | 71% | Elected | — |
| 2. The selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025 | 74,500,950 | 776,953 | 306,351 | -- | 0 | 99% | Approved | — |
| 3. Non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote) | 19,179,927 | 16,164,644 | 3,583,400 | -- | 36,656,283 | 54.3% | Approved | — |
| 4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment") | 27,741,397 | 7,585,461 | 3,601,113 | -- | 36,656,283 | 79% | Approved | — |
Source: COHERUS BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
118 asset managers disclosed a vote on at least one COHERUS BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of COHERUS BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held June 11, 2025.
Combines 3 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Ali J. Satvat
COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Ali J. Satvat”): 27,759,763 for, 11,168,208 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 5,581,345 for, 2,143,537 withheld, 147,580 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 986,197 | Withhold |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 857,296 | Withhold |
| BlackRock | 525,254 | 0 | 105,554 | 0 | Mixed |
| Equitable | 22,008 | 0 | 0 | 188,410 | Mixed |
| Fidelity | 177,047 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 91,117 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 67,376 | Withhold |
| Goldman Sachs | 66,033 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 58,876 | 0 | 0 | 0 | For |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 34,806 | 0 | Abstain |
| Voya | 33,119 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 29,534 | Withhold |
| John Hancock | 29,316 | 0 | 0 | 0 | For |
| DWS | 17,544 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 9,819 | Withhold |
| ProShares | 7,748 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Meeting held June 11, 2025.
Combines 4 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jill O'Donnell-Tormey, Ph.D.
COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Jill O'Donnell-Tormey, Ph.D.”): 32,769,503 for, 6,158,468 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,644,699 for, 227,763 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 986,197 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| SEI | 857,296 | 0 | 0 | 0 | For |
| BlackRock | 630,808 | 0 | 0 | 0 | For |
| Equitable | 22,008 | 0 | 0 | 188,410 | Mixed |
| Fidelity | 177,047 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 91,117 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 67,376 | 0 | 0 | 0 | For |
| Goldman Sachs | 66,033 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 58,876 | 0 | 0 | 0 | For |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| Voya | 33,119 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 29,534 | Withhold |
| John Hancock | 29,316 | 0 | 0 | 0 | For |
| DWS | 17,544 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 9,819 | Withhold |
| ProShares | 7,748 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Meeting held June 11, 2025.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Michael Ryan
COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Ryan”): 32,735,184 for, 6,192,787 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,643,767 for, 228,695 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 986,197 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| SEI | 857,296 | 0 | 0 | 0 | For |
| BlackRock | 630,808 | 0 | 0 | 0 | For |
| Equitable | 22,008 | 0 | 0 | 188,410 | Mixed |
| Fidelity | 177,047 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 91,117 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 67,376 | 0 | 0 | 0 | For |
| Goldman Sachs | 66,033 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 58,876 | 0 | 0 | 0 | For |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| Voya | 33,119 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 29,534 | Withhold |
| John Hancock | 29,316 | 0 | 0 | 0 | For |
| DWS | 17,544 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 9,819 | Withhold |
| ProShares | 7,748 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Meeting held March 11, 2025; no official results are on file for this meeting.
100% of fund votes cast · no official result
Description as filed by funds: TO APPROVE THE TRANSACTION, THE ASSET PURCHASE AGREEMENT AND THE OTHER TRANSACTIONS AND ANCILLARY DOCUMENTS CONTEMPLATED BY THE ASSET PURCHASE AGREEMENT.
The 37 asset managers below reported 14,969,533 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,761,099 | 0 | 0 | 0 | For |
| SEI | 1,024,136 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| Charles Schwab | 689,973 | 0 | 0 | 0 | For |
| BlackRock | 635,979 | 0 | 0 | 0 | For |
| Equitable | 236,071 | 0 | 0 | 0 | For |
| Fidelity | 121,665 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 47,027 | 0 | 0 | 0 | For |
| Pacific Life | 46,380 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| Voya | 34,937 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| WisdomTree | 30,225 | 0 | 0 | 0 | For |
| AuguStar | 29,534 | 0 | 0 | 0 | For |
| John Hancock | 18,983 | 0 | 0 | 0 | For |
| Global X | 16,261 | 0 | 0 | 0 | For |
| Victory Capital | 13,627 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,327 | 0 | 0 | 0 | For |
| Nationwide | 11,892 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,450 | 0 | 0 | 0 | For |
| Calvert | 9,819 | 0 | 0 | 0 | For |
| ProShares | 8,318 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Meeting held June 11, 2025.
Combines 3 wordings of this item as funds reported it.
79% Approved · of votes cast
Description as filed by funds: To approve the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment").
COHERUS BIOSCIENCES INC.’s own tally for this item (“4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment")”): 27,741,397 for, 7,585,461 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment").”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,842,928 for, 29,534 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 986,197 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| SEI | 857,296 | 0 | 0 | 0 | For |
| BlackRock | 630,808 | 0 | 0 | 0 | For |
| Equitable | 210,418 | 0 | 0 | 0 | For |
| Fidelity | 177,047 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 91,117 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 67,376 | 0 | 0 | 0 | For |
| Goldman Sachs | 66,033 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 58,876 | 0 | 0 | 0 | For |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| Voya | 33,119 | 0 | 0 | 0 | For |
| AuguStar | 0 | 29,534 | 0 | 0 | Against |
| John Hancock | 29,316 | 0 | 0 | 0 | For |
| DWS | 17,544 | 0 | 0 | 0 | For |
| Calvert | 9,819 | 0 | 0 | 0 | For |
| ProShares | 7,748 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Meeting held June 11, 2025.
Combines 12 wordings of this item as funds reported it.
54.3% Approved · of votes cast
Prior year: 71.0% for (May 29, 2024 meeting) ▼ 16.7 pts
Description as filed by funds: To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote).
COHERUS BIOSCIENCES INC.’s own tally for this item (“3. A non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote)”): 19,179,927 for, 16,164,644 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved a non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote).”
Support: 54.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 986,197 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 900,000 | 0 | 0 | Against |
| SEI | 0 | 857,296 | 0 | 0 | Against |
| BlackRock | 630,808 | 0 | 0 | 0 | For |
| Equitable | 22,008 | 188,410 | 0 | 0 | Mixed |
| Fidelity | 0 | 177,047 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 91,117 | 0 | 0 | Against |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 0 | 67,376 | 0 | 0 | Against |
| Goldman Sachs | 0 | 66,033 | 0 | 0 | Against |
| Northern Trust | 0 | 63,724 | 0 | 0 | Against |
| AQR | 0 | 62,143 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 58,876 | 0 | 0 | Against |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| Voya | 0 | 33,119 | 0 | 0 | Against |
| AuguStar | 0 | 0 | 29,534 | 0 | Abstain |
| John Hancock | 0 | 29,316 | 0 | 0 | Against |
| DWS | 0 | 17,544 | 0 | 0 | Against |
| Calvert | 9,819 | 0 | 0 | 0 | For |
| ProShares | 0 | 7,748 | 0 | 0 | Against |
Fund voting reports, all 37 managers: 4,218,063 for, 3,624,865 against, 29,534 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 0 | 2,550,341 | 0 | 0 | Against |
| BlackRock | 2,122,944 | 0 | 0 | 0 | For |
| Kohlberg Kravis Roberts & Co. L.P. | 2,055,055 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 1,928,464 | 0 | 0 | Against |
| State Street | 1,067,631 | 5,705 | 0 | 0 | For |
| Charles Schwab | 0 | 986,197 | 0 | 0 | Against |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 900,000 | 0 | 0 | Against |
| SEI | 0 | 857,723 | 0 | 0 | Against |
| Stonepine Capital Management, LLC | 0 | 655,000 | 0 | 0 | Against |
| AQR | 0 | 480,374 | 0 | 0 | Against |
| Northern Trust | 0 | 479,139 | 0 | 0 | Against |
| STRS OHIO | 0 | 324,000 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 238,788 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 236,102 | 0 | 0 | Against |
| AllianceBernstein | 0 | 188,410 | 0 | 0 | Against |
| Vanguard | 97,023 | 33,039 | 0 | 0 | Mixed |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 101,584 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 91,117 | 0 | 0 | Against |
| Invesco | 0 | 58,872 | 0 | 0 | Against |
| JPMorgan | 50,862 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 50,000 | 0 | 0 | 0 | For |
| Rhumbline | 0 | 38,110 | 0 | 0 | Against |
| Voya | 0 | 33,119 | 0 | 0 | Against |
| Goldman Sachs | 0 | 30,958 | 0 | 0 | Against |
| John Hancock | 0 | 29,386 | 0 | 0 | Against |
Institutional-manager reports, all 93 managers: 5,726,122 for, 10,284,244 against, 13,000 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 11, 2025.
99% Approved · of votes cast
Prior year: 99.3% for (May 29, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: TO RATIFY THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
COHERUS BIOSCIENCES INC.’s own tally for this item (“2. The selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025”): 74,500,950 for, 776,953 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,841,996 for, 932 against, 29,534 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,202,385 | 0 | 0 | 0 | For |
| Charles Schwab | 986,197 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 900,000 | 0 | 0 | 0 | For |
| SEI | 857,296 | 0 | 0 | 0 | For |
| BlackRock | 630,808 | 0 | 0 | 0 | For |
| Equitable | 210,418 | 0 | 0 | 0 | For |
| Fidelity | 177,047 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 91,117 | 0 | 0 | 0 | For |
| Lincoln Financial | 83,905 | 0 | 0 | 0 | For |
| WisdomTree | 80,178 | 0 | 0 | 0 | For |
| Global X | 67,376 | 0 | 0 | 0 | For |
| Goldman Sachs | 66,033 | 0 | 0 | 0 | For |
| Northern Trust | 63,724 | 0 | 0 | 0 | For |
| AQR | 62,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 58,876 | 0 | 0 | 0 | For |
| Pacific Life | 50,901 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 46,319 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,829 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,806 | 0 | 0 | 0 | For |
| Voya | 33,119 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 29,534 | 0 | Abstain |
| John Hancock | 29,316 | 0 | 0 | 0 | For |
| DWS | 17,544 | 0 | 0 | 0 | For |
| Calvert | 9,819 | 0 | 0 | 0 | For |
| ProShares | 7,748 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 114,725,740 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.79% |
| 2 | Charles Schwab | 0.86% |
| 3 | Delaware/Macquarie | 0.78% |
| 4 | SEI | 0.75% |
| 5 | BlackRock | 0.55% |
| 6 | Equitable | 0.18% |
| 7 | Fidelity | 0.15% |
| 8 | BRIDGEWAY FUNDS INC | 0.08% |
| 9 | Lincoln Financial | 0.07% |
| 10 | WisdomTree | 0.07% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rubric Capital Management LP | 2.22% |
| 2 | BlackRock | 1.85% |
| 3 | Kohlberg Kravis Roberts & Co. L.P. | 1.79% |
| 4 | C WorldWide Asset Management Fondsmaeglerselskab A/S | 1.68% |
| 5 | State Street | 0.94% |
| 6 | Charles Schwab | 0.86% |
| 7 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0.78% |
| 8 | SEI | 0.75% |
| 9 | Stonepine Capital Management, LLC | 0.57% |
| 10 | AQR | 0.42% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 11,151,905 | 9.72% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 10,978,359 | 9.57% | Form 13F, quarter ended March 31, 2025 |
| Evgeny Zaytsev ("Zaytsev") | 7,602,708 | 6.63% | Schedule 13G, filed November 4, 2025 |
| Thomas A. Satterfield, Jr. | 6,930,000 | 6.04% | Schedule 13G, filed April 29, 2026 |
| Ali J. Satvat | 3,036,576 | 2.65% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Millennium Management | 2,899,952 | 2.53% | Form 13F, quarter ended March 31, 2025 |
| State Street | 2,226,851 | 1.94% | Form 13F, quarter ended March 31, 2025 |
| Dennis M. Lanfear | 1,204,723 | 1.05% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Northern Trust | 947,124 | 0.83% | Form 13F, quarter ended March 31, 2025 |
| Goldman Sachs | 547,707 | 0.48% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 114,725,740 shares outstanding, as reported by COHERUS BIOSCIENCES INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At COHERUS BIOSCIENCES INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held March 11, 2025 and June 11, 2025), 118 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 856 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 11, 2025 — To vote on a non-binding, advisory basis to approve the compensation of the Company's named… — COHERUS BIOSCIENCES INC.'s filing reports the proposal as approved, with 54.3% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: COHERUS BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COHERUS BIOSCIENCES INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
COHERUS BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “COHERUS BIOSCIENCES (CHRS) 2025 Annual & Special Meetings”, https://proxyvotesnow.com/company/coherus-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.